1.52
Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
Prepare Yourself for Liftoff: MaxCyte Inc (MXCT) - setenews.com
Healthy Upside Potential: MaxCyte Inc (MXCT) - setenews.com
Mirabella Financial Services LLP Has $14.39 Million Stock Position in MaxCyte, Inc. $MXCT - MarketBeat
How MaxCyte Inc. (MYE0) stock compares with market leadersWeekly Stock Report & Smart Swing Trading Techniques - Newser
Is MaxCyte Inc. (MYE0) stock attractive post correction2025 Top Gainers & Daily Price Action Insights - Newser
Can MaxCyte Inc. (MYE0) stock stage a strong rebound this quarterJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - Newser
Is MaxCyte Inc. stock attractive for ETFsTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Why analysts recommend MaxCyte Inc. (MYE0) stockJuly 2025 Trends & Weekly Setup with ROI Potential - Newser
Is MaxCyte Inc. (MYE0) stock dividend growth reliableAnalyst Upgrade & Stepwise Trade Execution Plans - Newser
MaxCyte drives CAR T manufacturing optimization using ExPERT system - Traders Union
Dividend Watch: Why Clearway Energy Inc. (NY4B) stock is upgraded to buyJuly 2025 Volume & Verified Technical Signals - BỘ NỘI VỤ
MaxCyte (MXCT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO - Morningstar
Will MaxCyte Inc. stock attract more institutional investors - moha.gov.vn
The time has not yet come to remove your chips from the table: MaxCyte Inc (MXCT) - setenews.com
MaxCyte aims to optimize CAR T manufacturing with ExPERT system - Traders Union
MaxCyte (NASDAQ:MXCT) Stock Rating Upgraded by Wall Street Zen - Defense World
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Analysts - MarketBeat
MaxCyte: Building the Future of Cell and Gene Therapy Innovation - MSN
MXCT SEC FilingsMaxcyte 10-K, 10-Q, 8-K Forms - Stock Titan
What drives MaxCyte Inc MYE0 stock priceRSI Overbought/Oversold & Daily Tips From Top Market Analysts - earlytimes.in
How MaxCyte Inc. (MYE0) stock reacts to fiscal policiesJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com
Can MaxCyte Inc. (MYE0) stock reach $200 price target2025 Major Catalysts & Weekly High Return Opportunities - newser.com
MaxCyte explores electroporation's role in cell therapy innovation - Traders Union
How MaxCyte Inc. (MYE0) stock behaves under inflation pressureEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
What Wall Street predicts for MaxCyte Inc. stock priceQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
MaxCyte drives cell engineering focus at Advanced Therapies USA - Traders Union
MaxCyte Announces Major Workforce Reduction Plan - MSN
Is MaxCyte Inc. stock a buy in volatile marketsJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
MaxCyte at Stephens Annual Investment Conference: Strategic Restructuring Amid Market Challenges By Investing.com - Investing.com Canada
Will MaxCyte Inc. stock split again soonTrade Risk Report & Daily Profit Maximizing Tips - newser.com
A Look at MaxCyte Inc (MXCT) Shares in the Recent Past Indicates Growth - Setenews
Is MaxCyte Inc. (MYE0) stock nearing a technical breakoutPortfolio Gains Summary & Community Consensus Picks - newser.com
MXCT: SecureDx integration and new product launches position for growth as industry rationalizes - TradingView
What dividend safety rating applies to MaxCyte Inc. (MYE0) stockIPO Watch & Safe Capital Growth Trade Ideas - newser.com
How MaxCyte Inc. (MYE0) stock trades under stagflation2025 Performance Recap & Entry Point Strategy Guides - newser.com
FY2025 EPS Estimates for MaxCyte Boosted by William Blair - Defense World
Will MaxCyte Inc. (MYE0) stock see valuation expansionJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
How buyback programs support MaxCyte Inc. (MYE0) stockTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
What MACD signals say about MaxCyte Inc.July 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):